YOUR BUSINESS AUTHORITY
Springfield, MO
Bristol Myers Squibb Co. was sued for $6.4 billion late last week.
The company is accused of allegedly delaying its Breyanzi cancer drug to avoid payments to shareholders of Celgene Corp., which it purchased in 2019.
The lawsuit was filed by UMB Bank, which is acting as a trustee on behalf of Celgene's former shareholders.
Read more from Reuters.
Nixa Superintendent Gearl Loden weighs in on A-F grade cards.
Thanksgiving staple recalled at Costco
HBA of Greater Springfield executive officer to retire
Warren Buffett donates $5.5B worth of Berkshire Hathaway shares
Transportation officials discuss $471M Forward 44 initiative
Monday Morning Business Leads: Nov. 16, 2026
Ozarks Farm Stop remains open after car crashes into building
Letter to the Editor: No half-baked cake for our kids. No half-baked school grades, either.